Mail

UK markets close in 2 hours 47 minutes

FTSE 100
8,304.49
+91.00(+1.11%)
FTSE 250
20,404.99
+240.45(+1.19%)
AIM
777.53
+6.00(+0.78%)
GBP/EUR
1.1645
-0.0014(-0.12%)
GBP/USD
1.2552
-0.0012(-0.10%)
Bitcoin GBP
50,638.05
-272.54(-0.54%)

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Teva Pharmaceutical Industries Limited (0LER.IL)

IOB - IOB Delayed price. Currency in USD

Add to watchlist

13.98

+0.16

(+1.16%)

As of 07:06PM BST. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	15.72B
Enterprise value	32.65B
Trailing P/E	N/A
Forward P/E	5.81
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.98
Price/book (mrq)	2.09
Enterprise value/revenue	2.06
Enterprise value/EBITDA	20.96

Trading information

Stock price history

Beta (5Y monthly)	1.15
52-week change ³	52.76%
S&P500 52-week change ³	25.77%
52-week high ³	14.48
52-week low ³	0.00
50-day moving average ³	13.59
200-day moving average ³	10.99

Share statistics

Avg vol (3-month) ³	93.33k
Avg vol (10-day) ³	72.05k
Shares outstanding ⁵	1.12B
Implied shares outstanding ⁶	1.38B
Float ⁸	1.12B
% held by insiders ¹	0.00%
% held by institutions ¹	49.63%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Jun 2023

Profitability

Profit margin	-14.88%
Operating margin (ttm)	16.52%

Management effectiveness

Return on assets (ttm)	3.48%
Return on equity (ttm)	-26.58%

Income statement

Revenue (ttm)	15.02B
Revenue per share (ttm)	13.47
Quarterly revenue growth (yoy)	2.40%
Gross profit (ttm)	6.97B
EBITDA	3.71B
Net income avi to common (ttm)	-2.23B
Diluted EPS (ttm)	-1.90
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	2.67B
Total cash per share (mrq)	2.38
Total debt (mrq)	21.02B
Total debt/equity (mrq)	272.65%
Current ratio (mrq)	1.02
Book value per share (mrq)	6.29

Cash flow statement

Operating cash flow (ttm)	1.7B
Levered free cash flow (ttm)	3.08B